1. Home
  2. FWRD vs ARVN Comparison

FWRD vs ARVN Comparison

Compare FWRD & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Air Corporation

FWRD

Forward Air Corporation

HOLD

Current Price

$15.09

Market Cap

573.9M

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$7.04

Market Cap

600.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWRD
ARVN
Founded
1981
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
573.9M
600.2M
IPO Year
2024
2018

Fundamental Metrics

Financial Performance
Metric
FWRD
ARVN
Price
$15.09
$7.04
Analyst Decision
Buy
Buy
Analyst Count
5
16
Target Price
★ $24.50
$13.93
AVG Volume (30 Days)
391.2K
★ 657.0K
Earning Date
11-09-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 88.54
58.84
EPS
N/A
★ 1.70
Revenue
★ $1,269,573,000.00
$262,600,000.00
Revenue This Year
$3.56
$12.76
Revenue Next Year
$0.50
N/A
P/E Ratio
★ N/A
$4.10
Revenue Growth
N/A
★ N/A
52 Week Low
$7.86
$6.74
52 Week High
$31.18
$14.22

Technical Indicators

Market Signals
Indicator
FWRD
ARVN
Relative Strength Index (RSI) 44.93 38.65
Support Level $14.84 N/A
Resistance Level $16.76 $7.74
Average True Range (ATR) 0.73 0.33
MACD 0.03 -0.00
Stochastic Oscillator 16.41 30.74

Price Performance

Historical Comparison
FWRD
ARVN

About FWRD Forward Air Corporation

Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in North and South America, Europe, and Asia.

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

Share on Social Networks: